🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 20 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/06/1999 | 37,90 | 38,37 | 37,43 | 37,66 | +0,00% | 2,47% | 50.628 |
| 01/06/1999 | 38,37 | 38,60 | 37,43 | 37,66 | -1,83% | 3,05% | 68.101 |
| 28/05/1999 | 38,83 | 38,83 | 37,43 | 38,37 | +2,50% | 3,61% | 49.239 |
| 27/05/1999 | 40,00 | 40,94 | 37,43 | 37,43 | -6,98% | 8,77% | 42.854 |
| 26/05/1999 | 42,11 | 42,11 | 40,24 | 40,24 | -3,37% | 4,44% | 33.049 |
| 25/05/1999 | 42,11 | 42,11 | 39,30 | 41,64 | +2,30% | 6,67% | 64.521 |
| 24/05/1999 | 41,17 | 41,64 | 39,77 | 40,70 | +1,16% | 4,55% | 38.098 |
| 21/05/1999 | 41,64 | 42,11 | 40,24 | 40,24 | -2,82% | 4,49% | 38.178 |
| 20/05/1999 | 41,17 | 42,81 | 40,24 | 41,41 | +2,91% | 6,25% | 66.177 |
| 19/05/1999 | 40,47 | 40,94 | 39,54 | 40,24 | +0,00% | 3,47% | 36.976 |
| 18/05/1999 | 39,30 | 40,24 | 39,07 | 40,24 | +2,38% | 2,98% | 45.525 |
| 17/05/1999 | 38,37 | 40,24 | 38,37 | 39,30 | +2,44% | 4,88% | 61.288 |
| 14/05/1999 | 38,83 | 39,07 | 38,13 | 38,37 | -1,20% | 2,41% | 104.703 |
| 13/05/1999 | 39,30 | 40,24 | 38,37 | 38,83 | +2,47% | 4,76% | 71.414 |
| 12/05/1999 | 39,54 | 39,54 | 37,90 | 37,90 | -4,14% | 4,14% | 51.136 |
| 11/05/1999 | 40,00 | 40,00 | 37,43 | 39,54 | +0,60% | 6,43% | 53.487 |
| 10/05/1999 | 40,00 | 41,17 | 38,37 | 39,30 | +1,82% | 7,02% | 49.533 |
| 07/05/1999 | 38,60 | 38,83 | 37,43 | 38,60 | +4,43% | 3,64% | 44.136 |
| 06/05/1999 | 38,13 | 39,07 | 36,96 | 36,96 | -2,47% | 5,52% | 45.846 |
| 05/05/1999 | 37,43 | 39,07 | 37,43 | 37,90 | -1,22% | 4,38% | 37.270 |
| 04/05/1999 | 36,73 | 38,37 | 36,49 | 38,37 | +3,14% | 5,10% | 59.952 |
| 03/05/1999 | 36,03 | 37,43 | 36,03 | 37,20 | +0,63% | 3,90% | 26.236 |
| 30/04/1999 | 37,66 | 38,37 | 36,49 | 36,96 | -0,63% | 4,97% | 19.557 |
| 29/04/1999 | 38,13 | 40,24 | 36,73 | 37,20 | -1,24% | 9,20% | 41.170 |
| 28/04/1999 | 39,30 | 40,24 | 37,43 | 37,66 | -6,94% | 7,14% | 41.438 |
| 27/04/1999 | 37,90 | 41,17 | 37,90 | 40,47 | +9,49% | 8,64% | 156.934 |
| 26/04/1999 | 33,92 | 36,96 | 33,92 | 36,96 | +8,97% | 8,97% | 68.421 |
| 23/04/1999 | 33,22 | 34,15 | 33,22 | 33,92 | +0,69% | 2,82% | 26.236 |
| 22/04/1999 | 33,92 | 34,15 | 33,22 | 33,69 | +0,00% | 2,76% | 30.030 |
| 21/04/1999 | 32,75 | 34,04 | 32,28 | 33,69 | +2,86% | 5,36% | 29.682 |